Search
Now showing items 21-30 of 355
Usefulness of FSH measurements for determining menopause in long-term users of depot medroxyprogesterone acetate over 40 years of age
(Elsevier Science IncNew YorkEUA, 2007)
Forearm bone density in long-term users of oral combined contraceptives and depot medroxyprogesterone acetate
(Elsevier Science IncNew YorkEUA, 2001)
Forearm bone mineral density in postmenopausal former users of depot medroxyprogesterone acetate
(Elsevier Science IncNew YorkEUA, 2008)
Pharmacokinetic interactions between depot medroxyprogesterone acetate and combination antiretroviral therapy
(Elsevier Science IncNew YorkEUA, 2008)
Body Composition, Resting Energy Expenditure And Inflammatory Markers: Impact In Users Of Depot Medroxyprogesterone Acetate After 12 Months Follow-up
(SBEM-Soc Brasil Endocrinologia & MetabologiaRio de Janeiro, 2017)